Affiliation:
1. Loughborough University, UK
Abstract
Neuropsychological testing is necessary to assess cognitive functions in individuals who exhibit signs of mild cognitive impairment (MCI) and dementia. This chapter presents the most commonly used cognitive assessments for MCI and dementia in healthcare and academia, including information about normative data, and cut-off scores. Some of the tests presented are: the mini-mental state examination, trail making tests, montreal cognitive assessment, Alzheimer's disease assessment scale-cognitive, and clock drawing test. In addition, the chapter discusses the benefits of timely diagnosis and limitations in the testing assessments that might affect the quality of life in individuals with cognitive decline due to MCI and dementia diagnosis.
Reference136 articles.
1. Progression to Dementia in Clinical Subtypes of Mild Cognitive Impairment
2. Long-term test-retest reliability of the California Verbal Learning Test – second edition
3. Alzheimer’s Association. (2022). 10 Early Signs and Symptoms of Alzheimer’s. Alzheimer’s Association. https://www.alz.org/alzheimers-dementia/10_signs
4. Alzheimer’s Society. (2016). Fix Dementia Care: NHS and Care Homes. Alzheimer’s Association. https://www.alzheimers.org.uk/sites/default/files/migrate/downloads/fix_dementia_care_nhs_and_care_homes_report.pdf
5. American Psychiatric Association. (2022). Diagnostic and Statistical Manual of Mental Disorders (DSM-5-TRTM) (Fifth Edit). APA.